FRIGO, MAURA
FRIGO, MAURA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Eculizumab as a Disease-Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): A Case Report
2025 Schilke, E; Cereda, D; Fusco, M; Stanzani, L; Marzorati, L; Ripolone, M; Bertolasi, L; Frigo, M; Molteni, F; Farina, N; Ferrarese, C; Cavaletti, G; Balducci, C
Corticosteroid treatment for acute hydrocephalus in neurosarcoidosis: a case report
2024 Schilke, E; Remoli, G; Cutellé, C; Balducci, C; Cereda, D; Fusco, M; Tremolizzo, L; Ferrarese, C; Appollonio, I; Frigo, M
Current use of fluid biomarkers as outcome measures in Multiple Sclerosis (MS): a review of ongoing pharmacological clinical trials
2024 Schilke, E; Remoli, G; Funelli, E; Galimberti, M; Fusco, M; Cereda, D; Balducci, C; Frigo, M; Cavaletti, G
Neuropathological hints from CSF and serum biomarkers in corticobasal syndrome (CBS): a systematic review
2024 Remoli, G; Schilke, E; Magi, A; Ancidoni, A; Negro, G; Da Re, F; Frigo, M; Giordano, M; Vanacore, N; Canevelli, M; Ferrarese, C; Tremolizzo, L; Appollonio, I
Use of fluid biomarkers in ongoing Clinical Trials on Multiple Sclerosis (MS)
2023 Schilke, E; Remoli, G; Galimberti, M; Funelli, E; Fusco, M; Frigo, M; Ferrarese, C
Chorea and basal ganglia hypermetabolism as indicators of APS and probable-APS
2022 Schilke, E; Cutellé, C; Frigo, M; Da Re, F; Appollonio, I; Ferrarese, C
Glutamatergic Homeostasis Impairment in Multiple Sclerosis Patients
2012 Gironi, M; Zoia, C; Vaghi, M; Mendozzi, L; Cavarretta, R; Frigo, M; Cavaletti, G; Ferrarese, C